PMID: 18205578Jan 22, 2008Paper

Screening for Chlamydia trachomatis at the time of routine Pap smear in general practice: a cluster randomised controlled trial

The Medical Journal of Australia
Francis J BowdenNicholas J Glasgow

Abstract

To determine whether asking general practitioners to offer chlamydia screening at the same time as Pap screening increases chlamydia screening rates. A pragmatic cluster randomised controlled trial. Doctors from 31 general practices in the Australian Capital Territory performing more than 15 Pap smear screens per year, and all women aged 16-39 years attending those practitioners between 1 November 2004 and 31 October 2005. Doctors in the intervention practices were asked to routinely offer combined chlamydia and Pap screening to eligible women; doctors in the control practices were asked to implement screening guidelines based on a risk assessment of the individual patient (ie, usual practice). Chlamydia screening rate per visit. There were 26 876 visits by eligible women during the study period: 16 082 to intervention practices and 10 794 to control practices. Chlamydia screening occurred during 6.9% (95% CI, 6.5%-7.3%) of visits to intervention practices and 4.5% (95% CI, 4.1%-4.9%) of visits to control practices. After controlling for clustering and potential confounders, there were twofold greater odds of chlamydia screening occurring during a visit by an eligible woman to an intervention practice than to a control practice...Continue Reading

References

Apr 1, 1983·American Journal of Clinical Pathology·S A DormanT F Smith
May 23, 1996·The New England Journal of Medicine·D ScholesW E Stamm
Jan 1, 1997·Journal of General Internal Medicine·N LurieJ S Slater
Mar 27, 2001·Journal of Women's Health & Gender-based Medicine·F AhmadI Hyman
Jun 10, 2003·Sexually Transmitted Infections·O KufejiA Hayward
Sep 30, 2003·Southern Medical Journal·Natalia V OsterAdele L Franks
Aug 2, 2005·Obstetrics and Gynecology·Gale R BursteinKathleen L Irwin
Aug 4, 2005·Diagnostic Cytopathology·Clementine M HawthorneMarluce Bibbo
Nov 11, 2005·Clinical Trials : Journal of the Society for Clinical Trials·Marion K CampbellJeremy M Grimshaw

❮ Previous
Next ❯

Citations

Nov 11, 2010·Sexual Health·Shailendra SawleshwarkarAdrian Mindel
Aug 15, 2014·Australian Journal of Primary Health·Anna YeungJane Hocking
Jan 19, 2016·Sexually Transmitted Diseases·Melanie M TaylorIna U Park
Nov 28, 2013·BMC Health Services Research·Ann Dadich, Hassan Hosseinzadeh
Sep 14, 2016·The Cochrane Database of Systematic Reviews·Nicola LowHannelore Götz
Aug 10, 2010·The Australian Journal of Rural Health·Roderick Reynolds, Tracey Oakman
Jan 22, 2008·The Medical Journal of Australia·Jane S HockingChristopher K Fairley
Jan 11, 2021·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Rebecca ZurMark Yudin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Health Affairs
Richard Wittrup
Caring : National Association for Home Care Magazine
Sam Geist
Nursing Times
B Belle-Fortune
Journal of Pediatric and Adolescent Gynecology
F M BiroP J Hillard
© 2021 Meta ULC. All rights reserved